BARRETT’S ESOPHAGUS AND ASSOCIATED RISK FACTORS AMONG PATIENTS IN NORTH OF IRAQ

  • Ali Abdulghani Ramadhan Department of Medicine, College of Medicine, University of Duhok, Duhok, Iraq.
Keywords: Barrett’s esophagus, reflux disease, upped endoscopy, Duhok

Abstract

https://doi.org/10.31386/dmj.2025.19.2.3

Background: Gastroesophageal reflux disease is a common condition affecting the upper gastrointestinal tract and results in substantial health loss. Its burden is increasing due to global population aging and growth. Barrett’s esophagus is an important complication of this disease and is the precursor of esophageal adenocarcinoma which remains a malignancy with poor prognosis.

Objective: To determine the prevalence of Barrett’s esophagus and its risk factors in Duhok, Iraq.

Patients and methods: This prospective study extended from February 2016 to August 2024 in 3 health facilities in Duhok-Iraq. It included 10000 patients referred to diagnostic endoscopy for any indication. The endoscopy was done using high definition gastroscopes and when Barrett’s esophagus was suspected on endoscopy, biopsies were taken using Seatle protocol.

Results: The age range was 18-92 years (mean=44.3 years).  The prevalence of BE was 0.5% on histopathology and 1.4% on endoscopy. Risk factors associated with BE were erosive reflux disease (OR= 23.7, P-value <0.0001), hiatus hernia (OR= 10.9, P-value <0.0001), smoking (OR= 2.8, P-value 0.0001), male sex (OR= 2.5, P-value 0.001), obesity (OR= 1.9, P-value 0.02) and age more than 50 years (OR= 1.8, P-value 0.03). Alcohol intake was not associated with BE (P-value 0.07).

Conclusion: The prevalence of BE in our area is lower than the rates reported in the literature. The risk factors for BE are erosive reflux disease, hiatus hernia, smoking, male sex, obesity and age more than 50 years. Alcohol intake was not associated with BE.

 

Downloads

Download data is not yet available.

References

1. Abdulwahhab SH, Al Hashimi BA, Alkhalidi NM. Prevalence and Associated Factors of Gastro-Esophageal Reflux Disease among a Sample of Undergraduate Medical Students in Baghdad. J Fac Med Baghdad. 2021; 63 (4): 163-70. DOI: https://doi.org/10.32007/jfacmedbagdad.6341865.
2. Wani IR, Showkat HI, Bhargav DK, Samer M.. Prevalence and Risk Factors for Barrett’s Esophagus in Patients with GERD in Northern India; Do Methylene Blue-directed Biopsies Improve Detection of Barrett’s Esophagus Compared the Conventional Method? Middle East J Dig Dis. 2014;6:228-36.
3. Ho, K.Y. (2011), From GERD to Barrett's esophagus: Is the pattern in Asia mirroring that in the West?. Journal of Gastroenterology and Hepatology, 26: 816-824. https://doi.org/10.1111/j.1440-1746.2011.06669.x
4. Weissman S, Chris-Olaiya A, Weber AT, Mehta TI, Doherty B, Nambudiri V, et al. Real-world prevalence of endoscopic findings in patients with gastroesophageal reflux symptoms: a cross-sectional study. Endosc Int Open. 2022; 10: E342–E6. https://doi.org/10.1055/a-1756-4594
5. Fouad YM, Makhlouf MM, Tawfik HM, el-Amin H, Ghany WA, el-Khayat HR. Barrett’s esophagus: Prevalence and risk factors in patients with chronic GERD in Upper Egypt. World J Gastroenterol. 2009; 15(28): 3511-5. https://doi.org/10.3748/wjg.15.3511.
6. Marques de Sá I, Marcos P, Sharma P, Dinis-Ribeiro M. The global prevalence of Barrett’s esophagus: A systematic review of the published literature. United European Gastroenterology Journal. 2020; 8(9):1086–105.
https://doi.org/10.1177/2050640620939376
7. McColl KEL. What is causing the rising incidence of esophageal adenocarcinoma in the West and will it also happen in the East? J Gastroenterol. 2019;54(8):669-73. https://doi.org/10.1007/s00535-019-01593-7.
8. Grille VJ, Campbell S, Gibbs JF, Bauer TL. Esophageal cancer: the rise of adenocarcinoma over squamous cell carcinoma in the Asian belt. J Gastrointest Oncol. 2021;12(2): S339-S49. https://doi.org/10.21037/jgo-2019-gi-08.
9. Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am. 2015; 44(2): 203–31. https://doi.org/10.1016/j.gtc.2015.02.001.
10. J.L. Herrera Elizondo, R. Monreal Robles, D. García Compean, E.I. González Moreno, O.D. Borjas Almaguer, H.J. Maldonado Garza, et al. Prevalence of Barrett’s esophagus: An observational study from a gastroenterology clinic. Revista de Gastroenterología de México. 2017;82:296-300. https://doi.org/10.1016/j.rgmx.2017.01.006.
11. Shiota S, Singh S, Anshasi A, El-Serag HB. The Prevalence of Barrett’s Esophagus in Asian Countries: A Systematic Review & Meta-analysis. Clin Gastroenterol Hepatol. 2015; 13(11):1907–18. https://doi.org/10.1016/j.cgh.2015.07.050
12. Hamade N, Weng G, Desai M, Chandrasekar VT, Dasari C, Kennedy K, et al. Significant decline in the prevalence of Barrett’s esophagus among patients with gastroesophageal reflux disease. Diseases of the Esophagus. 2021;34:1–5. https://doi.org/10.1093/dote/doaa131.
13. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392-99. https://doi.org/10.1053/j.gastro.2006.08.032
14. Weusten BLAM, Bisschops R, Dinis-Ribeiro M, di Pietro M, Pech O, Spaander MCW, et al. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2023; 55: 2176-440. https://doi.org/10.1055/a-2176-2440.
15. Fass R. Gastroesophageal Reflux Disease. N Engl J Med 2022;387:1207-16. https://doi.org/10.1056/NEJMcp2114026
16. Shah A, Shibli F, Kitayama Y, Fass R. The natural course of gastroesophageal
reflux disease: a critical appraisal of the literature. J Clin Gastroenterol 2021;55: 12-20. https://doi.org/10.1097/MCG.0000000000001419
17. Spechler SJ, Souza RF. Barrett’s Esophagus. N Engl J Med 2014;371:836-45. https://doi.org/10.1056/NEJMra1314704.
18. Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA 2013;310:627-36. https://doi.org/10.1001/jama.2013.226450
19. Tunc M, Boyuk B, Mavis O. Upper GIS Endoscopy Indications of Patients Consulted at Internal Medicine Outpatient Clinics and Data Obtained According to These Indications. Open Journal of Gastroenterology. 2016; 6(4):111-6.
https://doi.org/10.4236/ojgas.2016.64015
20. Brzački V, Mladenović B, Nenad Govedarović N. Prevalence and risk factors for Barrett’s esophagus in patients with chronic gastroesophageal reflux disease. Srp Arh Celok Lek. 2018; 1:1-16. https://doi.org/10.2298/SARH180625073B
21. Ma S, Tong Z, He Y, Zhang Y, Guo X, Qi X. Association between hiatal hernia and Barrett's esophagus: an updated meta-analysis with trial sequential analysis. Therap Adv Gastroenterol. 2024; 17:1-21. https://doi.org/10.1177/17562848231219234.
22. Witarto AP, Witarto BS, Pramudito SL, Ratri LC, Wairooy NAP, Konstantin T, et al. Risk factors and 26‑years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta‑analysis. Scientific Reports. 2023;13:1-14. https://doi.org/10.1038/s41598-023-42636-7
23. Wu PC, Chen YH, Wu FZ, Lin KH, Hsu CL, Chen CS, et al. Risk factors for Barrett’s esophagus in young adults who underwent upper gastrointestinal endoscopy in a health examination center. Ther Adv Gastroenterol. 2019;12: 1–11. https://doi.org/doi.org/10.1177/1756284819853
24. Stephanie M, Nour H, de Sá Inês M, Shanker K, Kevin K, Mario DR, et al. Gender differences in Barrett's esophagus and progression of disease: a systematic review and meta-analysis. Diseases of the esophagus. 2022. 35(5):doab075. https://doi.org/10.1093/dote/doab075
25. Qumseya BJ, Bukannan A, Gendy S, Ahemd Y, Sultan S, Bain P, Gross SA, et al. Systematic review and meta-analysis of prevalence and risk factors for Barrett’s esophagus. Gastrointestinal Endoscopy. 2019; 90 (5): 707-17. https://doi.org/10.1016/j.gie.2019.05.030
26. Lee SW, Lien HC, Chang CS, Chang CH, Ko CW, Yeh HZ. Differences of risk factors and clinical presentations in male and female Taiwanese individuals with Barrett's esophagus. Journal of the Chinese Medical Association. 2018; 81(10): 860-64. https://doi.org/10.1016/j.jcma.2017.12.007.
27. Ko MT, Thomas T, Holden E, Beales ILP, Alexandre L. The Association Between Obesity and Malignant Progression of Barrett’s Esophagus: A Systematic Review and Dose-Response Meta-Analysis. Clinical Gastroenterology and Hepatology. 2024;1:42-1565. https://doi.org/10.1016/j.cgh.2024.07.041.
Published
2025-12-20
How to Cite
1.
Abdulghani Ramadhan A. BARRETT’S ESOPHAGUS AND ASSOCIATED RISK FACTORS AMONG PATIENTS IN NORTH OF IRAQ. Duhok Medical Journal [Internet]. 20Dec.2025 [cited 24Jun.2026];19(2):20-. Available from: https://dmj.uod.ac/index.php/dmj/article/view/329